Immunogenicity 11379
Sample ID
3775
Response
Negative
Tumor Type
Cervical Carcinoma(HPV+)
Gene Symbol
TRPM3
Transcript ID
uc004aii.3
HLA INFO
C*04:01
TCR INFO
No TCR info found!
Full length protein sequence (328 aa)
MGKKW
1
RDAAE
6
MERGC
11
SDRED
16
NAESR
21
RRSRS
26
ASRGR
31
FAESW
36
KRLSS
41
KQGST
46
KRSGL
51
PSQQT
56
PAQKS
61
WIERA
66
FYKRE
71
CVHII
76
PSTKD
81
PHRCC
86
CGRLI
91
GQHVG
96
LTPSI
101
SVLQN
106
EKNES
111
RLSRN
116
DIQSE
121
KWSIS
126
KHTQL
131
SPTDA
136
FGTIE
141
FQGGG
146
HSNKA
151
MYVRV
156
SFDTK
161
PDLLL
166
HLMTK
171
EWQLE
176
LPKLL
181
ISVHG
186
GLQNF
191
ELQPK
196
LKQVF
201
GKGLI
206
KAAMT
211
TGAWI
216
FTGGV
221
NTGVI
226
RHVGD
231
ALKDH
236
ASKSR
241
GKICT
246
IGIAP
251
WGIVE
256
NQEDL
261
IGRDV
266
VRPYQ
271
TMSNP
276
MSKLT
281
VLNSM
286
HSHFI
291
LADNG
296
TTGKY
301
GAEVK
306
LRRQL
311
EKHIS
316
LQKIN
321
TSK
326
Mutation Information
DNA mutation:
None
Peptide Range:
33 ~ 57
Mut AA position:
45 (13 in Wild Type peptide)
Alignment
Wild Type:
"RGRFAESWKRLSSKQGSTKRSGLPS
||||||||||||.||||||||||||
Mutant:
RGRFAESWKRLSCKQGSTKRSGLPS"
Science, 2017
Landscape of immunogenic tumor antigens in successful immunotherapy of virally induced epithelial cancerGene Name (from Reference) TRPM3
Checkpoint
Blockade
None
ACT
None
Vaccination
None
Curative
Effect
None
minimal_peptide
None
Antigen
Type
TMG RNA
T-cell
Source
TILs
APC
Type
autologous DCs
Assay
IFNg ELISPOT assay